Issue 23, 2023

Design of non-cytotoxic 6,7-dihydroxycoumarin-5-carboxylates with antibiofilm activity against Staphylococcus aureus and Candida albicans

Abstract

The 6,7-dihydroxycoumarin-5-carboxylates DHCou and 4-Me-DHCou have been synthesized via five-step route including a propargyl-Claisen rearrangement as key step. The compounds show antibiofilm activity against Stapylococcus aureus and Candida albicans but lack the cytotoxic activity of parent 6,7-dihydroxycoumarines such as esculetin and 4-methylesculetin.

Graphical abstract: Design of non-cytotoxic 6,7-dihydroxycoumarin-5-carboxylates with antibiofilm activity against Staphylococcus aureus and Candida albicans

Supplementary files

Article information

Article type
Communication
Submitted
23 Feb 2023
Accepted
05 Apr 2023
First published
06 Apr 2023
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2023,21, 4744-4749

Design of non-cytotoxic 6,7-dihydroxycoumarin-5-carboxylates with antibiofilm activity against Staphylococcus aureus and Candida albicans

R. Zscherp, A. Chakrabarti, A. P. Lehmann, H. Schrey, H. Zeng, W. Collisi and P. Klahn, Org. Biomol. Chem., 2023, 21, 4744 DOI: 10.1039/D3OB00303E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements